China Universal Asset Management Company’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.6K | Buy |
43,931
+1,874
| +4% | +$2.12K | ﹤0.01% | 420 |
|
|
2025
Q1 | $61.4K | Sell |
42,057
-2,401
| -5% | -$3.51K | 0.01% | 399 |
|
|
2024
Q4 | $94.7K | Buy |
44,458
+4,239
| +11% | +$9.03K | 0.01% | 398 |
|
|
2024
Q3 | $113K | Buy |
40,219
+15,690
| +64% | +$43.9K | 0.01% | 349 |
|
|
2024
Q2 | $57.2K | Sell |
24,529
-7,819
| -24% | -$18.2K | 0.01% | 347 |
|
|
2024
Q1 | $145K | Buy |
32,348
+12,881
| +66% | +$57.6K | 0.02% | 330 |
|
|
2023
Q4 | $62.5K | Buy |
19,467
+15,170
| +353% | +$48.7K | 0.01% | 344 |
|
|
2023
Q3 | $13.6K | Buy |
4,297
+2,385
| +125% | +$7.56K | ﹤0.01% | 327 |
|
|
2023
Q2 | $9.5K | Sell |
1,912
-46
| -2% | -$229 | ﹤0.01% | 323 |
|
|
2023
Q1 | $9.67K | Buy |
1,958
+493
| +34% | +$2.44K | ﹤0.01% | 296 |
|
|
2022
Q4 | $9.22K | Buy |
1,465
+118
| +9% | +$742 | ﹤0.01% | 235 |
|
|
2022
Q3 | $15K | Buy |
+1,347
| New | +$15K | 0.01% | 170 |
|